RVD Light With Darratumumab in Patients Without Renal Failure

Dr. Vishwan: I would continue the Dara for at least two years if possible and then keep on Linnilitamide maintenance so that they don't have to stay on Bortesumib. In the patient without renal failure, who's not a transplant candidate, how do you approach these patients? You've always been a champion of the RVD light regimen in these patients.